ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Neoadjuvant Surgery Makes Radiation Unnecessary In Some Early Breast Cancer

September 26, 2008

NCI Tells CCOPs To Slow Patient Accrual To Clinical Trials, Prepare For Budget Cuts.

May 12, 2006

In Brief: Kennedy Seeing Comments On HAS Regulations; Shimkins History of Cancer Now Available

November 11, 1977

Chart of Core Grants

October 18, 1991

Onco TCS Induces Responses In Relapsed Aggressive NHL

February 28, 2003

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009